logo

For the Inventor, By the Inventor

Saint-Gély-du-Fesc, France

Claude Bernhart

This inventor holds 12 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Sanofi, Elf Sanofi, Sanofi-Aventis. Active years: 1982-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claude Bernhart. Retrieved from https://idiyas.com/inventor/claude-bernhart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.2

ph-index = 8

Forward Citations = 205(Granted Patents)


Location History:

  • St. Gely du Fesc, FR (1982)
  • Saint Gely du Fesc, FR (1982 - 2006)

Company Filing History:

goldMedal4 out of 1,547 
 
Sanofi
 patents
silverMedal3 out of 53 
 
Elf Sanofi
 patents
bronzeMedal2 out of 390 
 
Sanofi-Aventis
 patents
4. 1 out of 15 
 
C M Industries
 patents
5. 1 out of 1 
 
Elf Sanofi, a French Corp.
 patent
6. 1 out of 152 
 
Sanofi-Synthelabo
 patents

Years Active: 1982-2006

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 7148240 - Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same (2006-12-12),
2. 6949583 - Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same (2005-09-27),
3. 6946483 - Aminoalkenylbenzoyl-benzofuran or benzothiophene, method for preparing same and compositions containing same (2005-09-20),
4. 5559233 - Methods for preparing n-substituted heterocyclic derivatives (1996-09-24),
5. 5352788 - N-substituted heterocyclic derivatives (1994-10-04),
6. 5274104 - N-substituted heterocyclic derivatives useful in the treatment of (1993-12-28),
7. 5270317 - N-substituted heterocyclic derivatives, their preparation and the (1993-12-14),
8. 5268375 - Dinitrogen heterocyclic derivatives N-substituted by a biphenylmethyl (1993-12-07),
9. 4721710 - Derivatives of piperidinedione for protecting the myocardium presenting (1988-01-26),
10. 4542134 - Derivatives of .gamma.-butyrolactone with an anti-arrythmic activity and (1985-09-17),
11. 4356177 - Myocardium-protecting pyridine derivatives having an anti-arrhythmic (1982-10-26),
12. 4329343 - Pyrrole amides and therapeutic use thereof (1982-05-11),

Title: Claude Bernhart: Innovator in Cardiovascular Medicinal Products

Introduction

Claude Bernhart is a notable inventor based in Saint Gely du Fesc, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating cardiovascular conditions. With a total of 12 patents to his name, Bernhart's work has had a considerable impact on the pharmaceutical industry.

Latest Patents

Bernhart's latest patents include innovative compounds such as aminoalkoxybenzoyl-benzofuran and benzothiophene derivatives. These compounds are characterized by their potential use as medicinal products, specifically targeting pathological syndromes of the cardiovascular system. His inventions detail methods for preparing these derivatives and the pharmaceutical compositions that incorporate them, showcasing their therapeutic applications.

Career Highlights

Throughout his career, Claude Bernhart has worked with prominent companies in the pharmaceutical sector, including Sanofi and Elf Sanofi. His experience in these organizations has allowed him to refine his expertise in medicinal product development and patent innovation.

Collaborations

Bernhart has collaborated with notable professionals in his field, including Dino Nisato and Patrick Gautier. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Claude Bernhart's contributions to the field of medicinal chemistry, particularly in cardiovascular treatments, highlight his role as an influential inventor. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…